Financhill
Back

Arbutus Biopharma Vs. Strategy Industry Stock Comparison

Sell
20

ABUS
Arbutus Biopharma

Last Price:
$3.31
Seasonality Move:
4.69%
Sell
35

MSTR
Strategy

Last Price:
$262.89
Seasonality Move:
-5.49%
Sell
20
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.19. The Score for ABUS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Strategy (MSTR) is a Sell

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $262.55. The Score for MSTR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • MSTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $262.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing slight buying pressure.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.73 Sell
Chaikin Money Flow: 697520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.27 - 3.47) Sell
Bollinger Bands (100): (3.24 - 3.78) Sell

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -17.11 Sell
Relative Strength Index (14 RSI): 42.7 Sell
Chaikin Money Flow: 4725568 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (268.37 - 336.69) Sell
Bollinger Bands (100): (260.07 - 383.89) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.33 Sell
20-day SMA: 3.35 Sell
50-day SMA: 3.33 Sell
200-day SMA: 3.58 Sell
8-day EMA: 3.29 Sell
20-day EMA: 3.34 Sell
50-day EMA: 3.38 Sell
200-day EMA: 3.4 Sell

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 275.56 Sell
20-day SMA: 293.91 Sell
50-day SMA: 323.85 Sell
200-day SMA: 235.89 Buy
8-day EMA: 276.42 Sell
20-day EMA: 291.61 Sell
50-day EMA: 311.36 Sell
200-day EMA: 251.41 Buy

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.08 per share.

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):